During the lifetime of the IMPROvED project, PlGF gained wide-spread acceptance as an important preeclampsia risk biomarker, and early pregnancy preterm preeclampsia risk screening evolved into a separate clinical application. The gene discussed is PGF; the disease is preeclampsia.